The percentage of lymphocyte subsets in MDS patients was tested by FCM, including total T cells (CD3+), CD4+ T cells (CD3+CD4+), CD8+ T cells (CD3+CD8+), B cells (CD19+), and NK cells (CD16+CD56+). This evidence concerns the gene CD19 and myelodysplastic syndrome.